Twist Bioscience CorporationTWSTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank50
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-86.72M
↑ 25% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-114.99M
Historical baseline
PeriodValueYoY Change
TTM$-86.72M-14.7%
2025$-75.63M-9.3%
2024$-69.17M+59.4%
2023$-170.25M+24.7%
2022$-226.24M-62.4%
2021$-139.31M+8.4%
2020$-152.12M-48.1%
2019$-102.69M-47.0%
2018$-69.85M-20.7%
2017$-57.90M-